Editas Medicine (EDIT) EBITDA Margin Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) EBITDA Margin Growth (3y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Editas Medicine |
262.77 Mn |
262.77 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
13.66 Mn |
| Jun 30, 2025 |
-58,811.00 |
| Mar 31, 2025 |
-88,558.00 |
| Dec 31, 2024 |
18,146.00 |
| Sep 30, 2024 |
-10.70 Mn |
| Jun 30, 2024 |
60,150.00 |
| Mar 31, 2024 |
-502,703.00 |
| Dec 31, 2023 |
53,696.00 |
| Sep 30, 2023 |
-95,439.00 |
| Jun 30, 2023 |
-123,578.00 |
| Mar 31, 2023 |
29,722.00 |
| Dec 31, 2022 |
-64,979.00 |
| Sep 30, 2022 |
-13.61 Mn |
| Jun 30, 2022 |
67,753.00 |
| Mar 31, 2022 |
76,145.00 |
| Dec 31, 2021 |
9,533.00 |
| Sep 30, 2021 |
-52,144.00 |
| Jun 30, 2021 |
-1.41 Mn |
| Mar 31, 2021 |
-7,162.00 |
| Sep 30, 2020 |
44,011.00 |
